✦ LIBER ✦

Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia

✍ Scribed by B. Vicknasingam; M. Mazlan; R.S. Schottenfeld; M.C. Chawarski

Book ID: 116412592
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 143 KB
Volume: 111
Category: Article
ISSN: 0376-8716
DOI: 10.1016/j.drugalcdep.2010.03.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of buprenorphine versus buprenor

Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers

✍ E. C. Strain; K. Stoller; S. L. Walsh; G. E. Bigelow 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 113 KB

Pharmacokinetics of the combination tabl

Pharmacokinetics of the combination tablet of buprenorphine and naloxone

✍ C.Nora Chiang; Richard L Hawks 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 313 KB

The pharmacodynamic and pharmacokinetic

The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers

✍ Lisa S. Middleton; Paul A. Nuzzo; Michelle R. Lofwall; David E. Moody; Sharon L. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB

Blockade of hydromorphone effects by bup

Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphine

✍ Eric C. Strain; Sharon L. Walsh; George E. Bigelow 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 67 KB

Abuse liability of intravenous buprenorp

Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers

✍ Sandra D. Comer; Maria A. Sullivan; Suzanne K. Vosburg; Jeanne Manubay; Leslie A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB

Abuse liability of intravenous buprenorp

Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers

✍ Sandra D. Comer; Maria A. Sullivan; Suzanne K. Vosburg; Jeanne Manubay; Leslie A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB

## ABSTRACT **Background** Sublingual buprenorphine is an effective maintenance treatment for opioid dependence, yet intravenous buprenorphine misuse occurs. A buprenorphine/naloxone formulation was developed to mitigate this misuse risk. This randomized, double‐blind, cross‐over study was conducte